Overview
Capeypharma distributes medical products under the Babycap, Mermaid and Olivocap brands. Its range includes products for nasal hygiene and cleansing, including nasal microsprays.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 7 days early.
- 202508/07/2026
- 202408/07/2025
- 202305/07/2024
- 202212/07/2023
The statements for 2022 report only zeros (no activity).
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Medical devices
- Sodium chloride solution
- Nasal hygiene products
- Lozenges
- Propolis products
Clients and partners
Website technology
- Website
- WordPress
Trademarks
Capeypharma holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2011.
| Mark | Protected until | |
|---|---|---|
| CapeyPharma | Feb 15, 2031 |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Krzysztof Koczorowskiage 64 | 3,220 | $43,490.01 | 20% |
Konrad Koczorowskiage 30 | 4,025 | $54,362.51 | 25% |
Piotr Czesław Koczorowskiage 61 | 5,635 | $76,107.51 | 35% |
Paweł Lewandowskiage 46 | 3,220 | $43,490.01 | 20% |
Piotr Czesław Koczorowski, Konrad Koczorowski and Andrzej Krzysztof Koczorowski hold a combined 80% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-10-01.
66 2490 0005 0000 4600 1604 0613- 50 2490 0005 0000 4600 2826 5132
- 33 2490 0005 0000 4600 8878 8879
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 1, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Eumedsp. z o.o. | $2,086,044.24 | eumed.pl | ||
| Passimedsp. z o.o. | $1,761,047.56 | passimed.pl | ||
| Farmedicasp. z o.o. | $1,689,796.86 | farmedica.pl | ||
| Pilomaxsp. z o.o. | $1,200,996.54 | pilomax.pl | ||
| Ideal Polandsp. z o.o. | $1,092,652.45 | ideal-poland.pl | ||
| Aprodsp. z o.o. | $994,275.26 | aprod.pl | ||
| Dominat Tradesp. z o.o. | $905,729.10 | dominat.org.pl | ||
| Pro Pedissp. z o.o. | $635,740.48 | propedis.pl | ||
| Support-Pharmasp. z o.o. | $521,132.71 | support-pharma.pl | ||
| PZ Cussons PolskaS.A. | $313,974.28 | pzcussons.com |
FAQ
Last updated: 2026-07-15